A biopsy was performed, revealing a histological diagnosis of nodular sclerosis Hodgkin lymphoma (NSHL), stage IIA (CD30+, CD15+, CD45-, CD20-, CD42 Ro-, CD68-, EMA-, and S100-Citokeratyn-). This evidence concerns the gene PTPRC and nodular sclerosis classical Hodgkin lymphoma.